Search

Author/Creator Nadler, Paul

1. ACTR-64. PHASE 2 STUDY OF SYM004 FOR ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). (6th November 2017)

Authors:
Desjardins, Annick; Randazzo, Dina; Peters, Katherine B; Johnson, Margaret O; Massey, Woody; Herndon, James E; McSherry, Frances; Lipp, Eric S; Nadler, Paul; Horak, Ivan D; Friedman, Henry S
Journal:
Neuro-oncology
Issue:
Volume 19(2017)Supplement 6
Page Start:
vi14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P856 AVID200, first-in-class TGF-beta1 and beta3 selective inhibitor: results of a phase 1 monotherapy dose escalation study in solid tumors and evidence of target engagement in patients. (15th April 2020)

Authors:
Yap, Timothy; Araujo, Daniel; Wood, Debra; Denis, Jean-François; Gruosso, Tina; Tremblay, Gilles; O'Connor-McCourt, Maureen; Ghosh, Ria; Sinclair, Sandra; Nadler, Paul; Siu, Lilian; Lakhani, Nehal
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 1
Page Start:
A6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search